Global DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Region: Trend Forecast and Growth Opportunity
Global DNA sequencing market will reach $52,278.1 million by 2031, growing by 15.4% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.
Highlighted with 81 tables and 89 figures, this 164-page report “Global DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Region.
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Sequencing Services
Based on Sequencing Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Sanger Sequencing
• Next Generation Sequencing
• Other Sequencing Types
By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Chain Termination Sequencing
• Pyrosequencing
• Sequencing by Ligation (SBL)
• Single-Molecule Real-Time Sequencing (SMRT)
• Nanopore Sequencing
• Other Technologies
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biomarker Discovery
• Diagnostics
• Personalized Medicine
• Reproductive Health
• Forensics
• Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Academics and Research Organizations
• Pharmaceutical and Biotechnology Companies
• Hospitals & Clinics
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Offering, Sequencing Type and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Global Market by Offering 44
3.1 Market Overview by Offering 44
3.2 Instruments 46
3.3 Consumables 47
3.4 Sequencing Services 48
4 Segmentation of Global Market by Sequencing Type 49
4.1 Market Overview by Sequencing Type 49
4.2 Sanger Sequencing 51
4.3 Next Generation Sequencing 52
4.4 Other Sequencing Types 53
5 Segmentation of Global Market by Technology 54
5.1 Market Overview by Technology 54
5.2 Sequencing by Synthesis 56
5.3 Ion Semiconductor Sequencing 57
5.4 Chain Termination Sequencing 58
5.5 Pyrosequencing 59
5.6 Sequencing by Ligation (SBL) 60
5.7 Single-Molecule Real-Time Sequencing (SMRT) 61
5.8 Nanopore Sequencing 62
5.9 Other Technologies 63
6 Segmentation of Global Market by Application 64
6.1 Market Overview by Application 64
6.2 Biomarker Discovery 66
6.3 Diagnostics 67
6.4 Personalized Medicine 68
6.5 Reproductive Health 69
6.6 Forensics 70
6.7 Other Applications 71
7 Segmentation of Global Market by End User 72
7.1 Market Overview by End User 72
7.2 Academics and Research Organizations 74
7.3 Pharmaceutical and Biotechnology Companies 75
7.4 Hospitals & Clinics 76
7.5 Other End Users 77
8 Segmentation of Global Market by Region 78
8.1 Geographic Market Overview 2021-2031 78
8.2 North America Market 2021-2031 by Country 82
8.2.1 Overview of North America Market 82
8.2.2 U.S. 86
8.2.3 Canada 89
8.2.4 Mexico 91
8.3 European Market 2021-2031 by Country 93
8.3.1 Overview of European Market 93
8.3.2 Germany 97
8.3.3 U.K. 99
8.3.4 France 101
8.3.5 Spain 103
8.3.6 Italy 105
8.3.7 Russia 107
8.3.8 Rest of European Market 109
8.4 Asia-Pacific Market 2021-2031 by Country 111
8.4.1 Overview of Asia-Pacific Market 111
8.4.2 Japan 115
8.4.3 China 118
8.4.4 Australia 120
8.4.5 India 122
8.4.6 South Korea 124
8.4.7 Rest of APAC Region 126
8.5 South America Market 2021-2031 by Country 128
8.5.1 Argentina 131
8.5.2 Brazil 133
8.5.3 Chile 135
8.5.4 Rest of South America Market 137
8.6 MEA Market 2021-2031 by Country 138
8.6.1 UAE 141
8.6.2 Saudi Arabia 143
8.6.3 South Africa 145
8.6.4 Other National Markets 147
9 Competitive Landscape 148
9.1 Overview of Key Vendors 148
9.2 New Product Launch, Partnership, Investment, and M&A 151
9.3 Company Profiles 152
Agilent Technologies Inc. 152
BGI Genomics Co., Ltd. 154
Bio-Rad Laboratories Inc. 155
Danaher Corporation (Integrated DNA Technologies Inc.) 156
Eurofins Scientific SE 157
F. Hoffmann-La Roche Ltd. 158
Illumina Inc. 159
Merck KGaA 160
Pacific Biosciences of California Inc. 161
PerkinElmer Inc. 162
Thermo Fisher Scientific Inc. 163
RELATED REPORTS 164